CFSAN Priorities: Industry & Consumer Groups Weigh In On NDIs And More
This article was originally published in The Tan Sheet
Executive Summary
FDA should accept safety findings from outside expert panels when reviewing new dietary ingredient notifications, CHPA says in Aug. 25 comments on CFSAN priorities